Literature DB >> 10419355

Plexiform neurofibroma of the cauda equina. Case report.

T D Nadkarni1, H L Rekate, S W Coons.   

Abstract

Plexiform neurofibroma of the cauda equina has been reported only twice previously. The authors report the first pediatric patient in whom such a tumor has been found. A 4-year-old boy presented with low-back pain that radiated bilaterally into the L-4 and L-5 dermatomes. A dermal sinus noted at the midthoracic level was surrounded by a hemangiomatous lesion. Magnetic resonance imaging confirmed the presence of the dermal sinus and revealed a well-defined lumbosacral mass that showed heterogeneous intensity with irregular enhancement. Intraoperatively, a solid mass, which engulfed the entire cauda equina, could not be dissected from the roots. The dermal sinus tract, however, was excised from the thoracic spine. The patient underwent radiotherapy to control the tumor and relieve his pain. Plexiform neurofibromas of the cauda equina are characterized by an insidious and progressive clinical course. The tumor mass may engulf all the roots of the cauda equina. No plexiform neurofibroma of the cauda equina has been reported to be associated with neurofibromatosis Type 1. The authors assume that the thoracic-level dermal sinus observed in this child was an incidental finding.

Entities:  

Mesh:

Year:  1999        PMID: 10419355     DOI: 10.3171/spi.1999.91.1.0112

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  2 in total

1.  Plexiform neurofibroma of the cauda equina with follow-up of 10 years: A case report.

Authors:  Zilvinas Chomanskis; Raimondas Juskys; Saulius Cepkus; Justyna Dulko; Vaiva Hendrixson; Osvaldas Ruksenas; Saulius Rocka
Journal:  World J Clin Cases       Date:  2022-05-16       Impact factor: 1.534

2.  Pelvic neurofibroma.

Authors:  Girish D Bakhshi; Mukund B Tayade; Rajesh B Yadav; Kavita V Jadhav; Sachin S Shenoy; Margi V Amin
Journal:  Clin Pract       Date:  2014-11-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.